These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3712215)

  • 1. Identification of a mouse serum protein increased by administration of an antitumor polysaccharide, PSK, as a variant of mouse transferrin and some of its biological activities.
    Kojima E; Mitsuno T; Osawa T
    J Pharmacobiodyn; 1986 Feb; 9(2):174-81. PubMed ID: 3712215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of PSK on the recovery of macrophage function in tumor-bearing mice].
    Ando T; Mastuda Y; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):827-34. PubMed ID: 6721504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of colony stimulating factors in mouse serum after injection of PSK, an antitumor polysaccharide.
    Satoh M; Ichimura O; Mitsuno T; Kojima E; Osawa T
    J Pharmacobiodyn; 1982 Oct; 5(10):818-28. PubMed ID: 6984462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of PSK, an antitumor protein-bound polysaccharides, by thymocyte electrophoresis.
    Iwaguchi T; Mori T; Kohsaki G
    J Pharmacobiodyn; 1984 Sep; 7(9):677-80. PubMed ID: 6441839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a biological response modifier, PSK, on intestinal flora of tumor-bearing mice.
    Sakurai K; Motokawa I; Ando T; Ohmura Y; Saito K; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    In Vivo; 1993; 7(2):175-9. PubMed ID: 8364170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of a Coliolus preparation, PSK: induction of macrophage chemotactic factor (MCF) in spleens of tumor bearing mice.
    Ishikawa K; Majima T; Ebina T
    Biotherapy; 1992; 5(4):251-8. PubMed ID: 1290721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PSK, a protein-bound polysaccharide from Coriolus versicolor, on drug-metabolizing enzymes in sarcoma-180 bearing and normal mice.
    Fujita H; Ogawa K; Ikuzawa M; Muto S; Matsuki M; Nakajima S; Shimamura M; Togawa M; Yoshikumi C; Kawai Y
    Int J Immunopharmacol; 1988; 10(4):445-50. PubMed ID: 3139576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK.
    Kanoh T; Matsunaga K; Saito K; Fujii T
    In Vivo; 1994; 8(2):247-50. PubMed ID: 7522606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin).
    Ikuzawa M; Matsunaga K; Nishiyama S; Nakajima S; Kobayashi Y; Andoh T; Kobayashi A; Ohhara M; Ohmura Y; Wada T
    Int J Immunopharmacol; 1988; 10(4):415-23. PubMed ID: 3170055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a serum glycoprotein that increased in OK-432-treated mice as hemopexin.
    Torikai T; Itoh O; Satoh M; Okumura O; Osawa T
    Gan; 1981 Feb; 72(1):92-7. PubMed ID: 7274653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
    Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Restoration of immunologic responsiveness by PSK in tumor-bearing animals].
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3468-75. PubMed ID: 3789758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of biological response modifiers with different modes of action used separately and together on immune responses in mice with syngeneic tumours.
    Matsunaga K; Morita I; Iijima H; Endoh H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
    J Int Med Res; 1992 Sep; 20(5):406-21. PubMed ID: 1280606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a serum glycoprotein whose content is increased in PSK-treated mice as haptoglobin.
    Mitsuno T; Shitara K; Kojima E; Osawa T
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3617-24. PubMed ID: 6671222
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimetastatic effect of PSK, a protein-bound polysaccharide, against the B16-BL6 mouse melanoma.
    Matsunaga K; Ohhara M; Oguchi Y; Iijima H; Kobayashi H
    Invasion Metastasis; 1996; 16(1):27-38. PubMed ID: 8830763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of iron and transferrin on the response of serum-free cultures of mouse lymphocytes to concanavalin A and lipopolysaccharide.
    Brock JH
    Immunology; 1981 Jun; 43(2):387-92. PubMed ID: 7251059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of protein-bound polysaccharide from Cordyceps ophioglossoides in mice.
    Ohmori T; Tamura K; Tsuru S; Nomoto K
    Jpn J Cancer Res; 1986 Dec; 77(12):1256-63. PubMed ID: 3102430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Anticancer Res; 1987; 7(3 Pt B):509-12. PubMed ID: 3631910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin binding and iron uptake by mouse lymph node cells during transformation in response to concanavalin A.
    Brock JH; Rankin MC
    Immunology; 1981 Jun; 43(2):393-8. PubMed ID: 7251060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK.
    Suo J; Tanaka N; Hizuta A; Yunoki S; Orita K
    Acta Med Okayama; 1994 Oct; 48(5):237-42. PubMed ID: 7863794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.